Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

16.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.9K
Frequency-dependent Selection01:21

Frequency-dependent Selection

24.4K
When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
24.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Types of Selection01:46

Types of Selection

45.9K
Natural selection influences the frequencies of particular alleles and phenotypes within populations in several different ways. Primarily, natural selection can be directional, stabilizing, or disruptive. Directional selection favors one extreme trait and shifts the population towards that phenotype while selecting against individuals displaying alternate traits. Stabilizing selection favors an intermediate trait with a narrow range of variation. Deviation from the optimal phenotype towards an...
45.9K
Inclusive Fitness00:57

Inclusive Fitness

43.2K
Most altruistic behavior—in which one animal helps another at a cost to themselves—occurs between relatives. Scientists think these altruistic behaviors evolved because they increase the inclusive fitness of the animal providing help.
43.2K
Synteny and Evolution02:31

Synteny and Evolution

3.9K
John H. Renwick first coined the term “synteny” in 1971, which refers to the genes present on the same chromosomes, even if they are not genetically linked. The species with common ancestry tend to show conserved syntenic regions. Therefore, the concept of synteny is nowadays used to describe the evolutionary relationship between species.
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ploidy shapes gemcitabine response through altered potency and delayed cell death.

bioRxiv : the preprint server for biology·2026
Same author

Pharmacokinetic Acceleration via CYP3A4 Hyperactivation as a Clinically Actionable Mechanism of Targeted Therapy Resistance in NSCLC.

bioRxiv : the preprint server for biology·2026
Same author

When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic Composition.

NPJ precision oncology·2026
Same author

Age identifies cancer drivers hidden within the genome.

Nature genetics·2026
Same author

Multifactorial sheltering in peristromal niches shapes in vivo responses of lung cancers to targeted therapies.

Nature communications·2026
Same author

Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumors.

Translational lung cancer research·2026
Same journal

Macropinocytosis: A central orchestrator in tumor development and therapeutic resistance.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

KIAA0101 in human cancers: From biomarker discovery to therapeutic targeting.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Post-translational modifications as hubs of amino acid metabolism in cancer: From oncogenic signaling to therapeutic targeting.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Senescence in non-cancerous cells within the tumor: What is the real deal?

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

The MYC network: Hub of malignancy and blueprint for intervention.

Biochimica et biophysica acta. Reviews on cancer·2026
Same journal

Redefining first-line standards: The role of next-generation HER2-Targeted therapies in HER2-positive metastatic breast cancer.

Biochimica et biophysica acta. Reviews on cancer·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.4K

Somatic clonal evolution: A selection-centric perspective.

Jacob Scott1, Andriy Marusyk2

  • 1Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH, USA.

Biochimica Et Biophysica Acta. Reviews on Cancer
|February 6, 2017
PubMed
Summary
This summary is machine-generated.

Cancer progression is driven by somatic clonal evolution, influenced by selection pressures, not just mutations. Understanding these evolutionary forces can improve cancer prevention and therapies.

Keywords:
CancerDriverInitiationNatural selectionProgressionSelective pressures

More Related Videos

Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.9K
Clonal Genetic Tracing using the Confetti Mouse to Study Mineralized Tissues
07:41

Clonal Genetic Tracing using the Confetti Mouse to Study Mineralized Tissues

Published on: October 23, 2019

15.8K

Related Experiment Videos

Last Updated: Mar 8, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.4K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.9K
Clonal Genetic Tracing using the Confetti Mouse to Study Mineralized Tissues
07:41

Clonal Genetic Tracing using the Confetti Mouse to Study Mineralized Tissues

Published on: October 23, 2019

15.8K

Area of Science:

  • Evolutionary biology
  • Cancer research
  • Cellular evolution

Background:

  • Cancer initiation and progression are widely attributed to somatic clonal evolution.
  • The prevailing view in cancer biology emphasizes "driver" mutations as the primary cause of evolution.
  • Selection forces are often overlooked or seen as mere constraints in tumor progression.

Purpose of the Study:

  • To propose a conceptual framework for somatic clonal evolution in cancer that prioritizes selection forces over the mutation-centric "driver gene" paradigm.
  • To highlight the potential of targeting selective pressures for cancer prevention and therapeutic enhancement.

Main Methods:

  • Review of existing literature on cancer evolution and Darwinian principles.
  • Comparative analysis of the "driver gene" paradigm versus a selection-centric model.
  • Discussion of the implications of evolutionary principles for cancer biology.

Main Results:

  • Somatic cell evolution, like natural populations, is governed by Darwinian principles including heritable variation and selection.
  • Focusing on selection pressures offers a more accurate conceptualization of cancer evolution than solely emphasizing mutations.
  • Selective pressures and resulting phenotypic adaptations can be manipulated for therapeutic benefit.

Conclusions:

  • Shifting focus to selection forces in somatic clonal evolution provides a more robust framework for understanding cancer.
  • Targeting selective pressures, rather than solely addressing mutations, holds promise for novel cancer therapies and prevention strategies.
  • Understanding the evolutionary dynamics of cancer is crucial for developing effective treatments.